Skip to main content
. 2021 Sep 15;13(9):10545–10553.

Table 3.

Comparison of clinical efficacy between the two groups

Research group (n=53) Control group (n=43) χ2 p
Complete response 27 (50.94%) 15 (34.88%)
Partial response 19 (35.85%) 14 (32.56%)
Stable disease 3 (5.66%) 6 (13.95%)
Progressive disease 4 (7.55%) 8 (18.60%)
Effective cure rate (%) 86.79% 67.44% 5.201 0.023*
*

denotes P<0.05.